ACTB-1003
ACTB-1003 is an oral kinase inhibitor that targets cancer mutations (inhibits FGFR), angiogenesis (inhibits VEGFR2 and Tie-2), and induces apoptosis (targets RSK and p70S6K downstream of PI3 kinase).
Supplier | Alfa Cytology |
---|---|
Product # | BC0443 |
Pricing | 5.0 mg, 10.0 mg, inquire |